24/7 Market News Snapshot 27 January, 2025 – Icad Inc (NASDAQ:ICAD)

January 27, 2025

DENVER, Colo., 27 January, 2025 (247marketnews.com) – (NASDAQ:ICAD) are discussed in this article.
iCAD Inc. (NASDAQ:ICAD) is experiencing significant bullish momentum, with its stock opening at $2.50 and currently trading at $2.87, representing an impressive gain of 18.60% from the previous close of $2.42. The trading volume has reached 1.06 million shares, indicating heightened investor interest that could signal potential for continued price movement. Investors are advised to monitor key resistance levels, while the substantial trading volume suggests a sustained upward trend.

In addition to this market activity, iCAD’s leadership is set to present at the BTIG 12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference, scheduled for February 11-12, 2025. Dana Brown, Chief Executive Officer, along with Chief Financial Officer Eric Lonnqvist, will conduct one-on-one meetings with investors, emphasizing iCAD’s commitment to enhancing early cancer detection through its advanced AI-powered solutions.

Simultaneously, iCAD has announced preliminary, unaudited financial results for the fourth quarter of 2024, projecting total revenue between $5.1 million and $5.3 million. This revenue outlook is bolstered by an Annual Recurring Revenue (T-ARR) estimated at approximately $9.8 million, reflecting a robust year-over-year growth of 11%. The quarter also marked the successful closure of 106 deals, including 19 cloud-based agreements catering to both new and existing clientele.

These developments showcase iCAD’s growing footprint in the breast health sector, driven by the adoption of its ProFound Breast Health Suite, which is positively impacting patient outcomes globally. With full audited financial results for 2024 expected in March, iCAD continues to reaffirm its dedication to innovation in cancer detection, all while forging valuable partnerships within the healthcare industry.

Related news for (ICAD)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.